NYX-458
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NYX-458, covering 2022-10-27 to 2022-10-27. Get the full timeline:
Most recent: Clinical Trial Update: NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking) [Phase 2]